Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Francesco Bartoli, Daniele Cavaleri, Bianca Bachi, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 230-238
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi, David Chen‐Li, Ella Krane, et al.
Journal of Psychiatric Research (2022) Vol. 151, pp. 693-709
Closed Access | Times Cited: 114
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Leila B. Giron, Michael J. Peluso, Jianyi Ding, et al.
JCI Insight (2022) Vol. 7, Iss. 15
Open Access | Times Cited: 49
Challenges and Opportunities for Celecoxib Repurposing
Urszula Bąk, Anna Krupa
Pharmaceutical Research (2023) Vol. 40, Iss. 10, pp. 2329-2345
Open Access | Times Cited: 27
Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis
Daniele Cavaleri, Francesco Bartoli, Chiara Alessandra Capogrosso, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110633-110633
Closed Access | Times Cited: 23
The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
Francesco Bartoli, R. Cioni, Daniele Cavaleri, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 19
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Gianluca Rosso, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Emerging Treatments for Bipolar Disorder
Nefize Yalın, Allan H. Young, Carlos A. Zarate
Oxford University Press eBooks (2025), pp. 329-346
Closed Access
Expanding treatment domains across psychiatric disorders
Alessandro Serretti
International Clinical Psychopharmacology (2025) Vol. 40, Iss. 2, pp. 49-52
Closed Access
Acoustic and Natural Language Markers for Bipolar Disorder: A Pilot, mHealth Cross-Sectional Study
Cristina Crocamo, R. Cioni, Aurelia Canestro, et al.
JMIR Formative Research (2025) Vol. 9, pp. e65555-e65555
Open Access
Efficacy and Safety of Antidiabetic Agents for Major Depressive Disorder and Bipolar Depression: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
Jian Zhang, Rongyi Sun, Yang Cai, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1172-1172
Open Access | Times Cited: 3
Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modelling
Daniele Cavaleri, Aldo De Pietra, Marco Gazzola, et al.
Psychoneuroendocrinology (2024) Vol. 168, pp. 107134-107134
Open Access | Times Cited: 3
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study
Francesco Bartoli, Tommaso Callovini, Daniele Cavaleri, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 7, pp. 1579-1586
Closed Access | Times Cited: 12
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
Maria Carolina Bittencourt Gonçalves, Roberta Andrejew, Carolina Gubert
CNS Drugs (2022) Vol. 36, Iss. 8, pp. 787-801
Open Access | Times Cited: 11
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Rodrigo Machado‐Vieira, Alan C. Courtes, Carlos A. Zarate, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
New “drugs and targets” in the GWAS era of bipolar disorder
Hao‐Xiang Qi, Xiao Xiao, Tao Li, et al.
Bipolar Disorders (2023) Vol. 25, Iss. 5, pp. 410-421
Closed Access | Times Cited: 4
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
Riccardo De Giorgi, Philip J. Cowen, Catherine J. Harmer
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 699-714
Open Access | Times Cited: 7
Study on association of serum uric acid levels with bipolar disorder: systematic review and meta-analysis in Chinese patients
Haihan Chen, Fengli Sun, Weidong Jin
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder – A nationwide cohort study
Jonne Lintunen, Markku Lähteenvuo, Antti Tanskanen, et al.
Journal of Affective Disorders (2022) Vol. 313, pp. 43-48
Open Access | Times Cited: 5
New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection
Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 37, pp. 3068-3081
Closed Access | Times Cited: 5
Risks of major affective disorders following a diagnosis of premenstrual dysphoric disorder: A nationwide longitudinal study
Dian‐Jeng Li, Shih‐Jen Tsai, Ya‐Mei Bai, et al.
Asian Journal of Psychiatry (2022) Vol. 79, pp. 103355-103355
Closed Access | Times Cited: 5
Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review
Prakamya Singal, Nicolás A. Núñez, Boney Joseph, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 547-547
Open Access | Times Cited: 2
GC-MS-based metabolomics analysis unravels the therapeutic potential of Neolamarckia cadamba fruit peel
Divya Selvakumar, V. Paranidharan, S. Vellaikumar, et al.
Journal of Phytology (2022), pp. 100-108
Open Access | Times Cited: 3
Antimanic‐like effect of dipyridamole in the methylphenidate‐induced hyperlocomotion
Anderson Gustavo Santos, Carlos Eduardo Kühl, Arisa Namie Higashijima, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 5, pp. 897-905
Closed Access
Computational biology approaches for drug repurposing
Tanya Waseem, Tausif Ahmed Rajput, Muhammad Saqlain Mushtaq, et al.
Progress in molecular biology and translational science (2024), pp. 91-109
Closed Access
Principles of computational drug designing and drug repurposing—An algorithmic approach
Angshuman Bagchi
Elsevier eBooks (2023), pp. 129-146
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top